Premium
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment
Author(s) -
Califf Robert M.,
Kramer Judith M.
Publication year - 2008
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.1617
Subject(s) - medicine , library science , family medicine , computer science